| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/11/1994 | WO1994010178A1 6-(substituted methylene) penems and intermediates |
| 05/11/1994 | WO1994010177A1 Cephem compounds, and their pharmaceutical compositions |
| 05/11/1994 | WO1994010176A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents |
| 05/11/1994 | WO1994010164A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | WO1994010163A1 Antimicrobial 5-hydrazino-quinolone derivatives |
| 05/11/1994 | WO1994010150A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aβ)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 05/11/1994 | WO1994010136A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009822A1 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS) |
| 05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 05/11/1994 | WO1994009810A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | WO1994009806A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | WO1994009793A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 05/11/1994 | WO1994009792A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | WO1994009781A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |
| 05/11/1994 | WO1994009779A1 Soluble calcium lactate/quindonecarboxylic acids on naphthydrinecarboxylic acids complexes as non-irritating parenteral forms |
| 05/11/1994 | WO1994009776A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
| 05/11/1994 | WO1994003620A3 Method of increasing expression of viral proteins |
| 05/11/1994 | EP0596802A1 Erythromycin derivatives, their process of preparation and their application as medicaments |
| 05/11/1994 | EP0596631A2 Novel polymeric antimicrobials and their use in pharmaceutical compositions |
| 05/11/1994 | EP0596542A1 Therapeutic nucleosides |
| 05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
| 05/11/1994 | EP0596298A2 5-Spirosubstituted 1-H-3-aryl-pyrrolidin-2,4-dione derivatives as herbicides, insecticides and acaricides |
| 05/11/1994 | EP0596112A1 Novel macrolide compound and production thereof |
| 05/11/1994 | EP0596058A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
| 05/11/1994 | EP0596024A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 05/11/1994 | EP0595970A1 Improved vaccine |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595890A1 Antimicrobial treatment methods and compositions |
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0440710B1 New antiviral agents |
| 05/11/1994 | CN1086515A Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent |
| 05/11/1994 | CN1086437A Method for inhibiting HIV replication using IL-4 |
| 05/11/1994 | CA2148455A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
| 05/11/1994 | CA2148368A1 Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes |
| 05/11/1994 | CA2148255A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | CA2148247A1 Rapamycin arylcarbonyl and alkoxycarbonyl as immunosuppressive and antifungal agents |
| 05/11/1994 | CA2148003A1 Antimicrobial 5-hydrazino-quinolone derivatives |
| 05/11/1994 | CA2148002A1 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-(8a.beta.)-6- isoquino lineamine derivatives, preparation method therefor and therapeutical usethereof |
| 05/11/1994 | CA2147877A1 Immunization against neisseria gonorrhoeae and neisseria meningitidis |
| 05/11/1994 | CA2147769A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | CA2147609A1 Cephem compounds, and their pharmaceutical compositions |
| 05/11/1994 | CA2147605A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | CA2146651A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | CA2145545A1 "sensitizing hiv-1 inhibitors" sensitize hiv infected individuals to "non-nucleoside hiv treatment drugs" |
| 05/11/1994 | CA2144652A1 Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
| 05/11/1994 | CA2143191A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/10/1994 | US5310898 Enzyme inhibitors |
| 05/10/1994 | US5310873 Cyclohexapeptide compound |
| 05/10/1994 | US5310740 Renin inhibitors |
| 05/10/1994 | US5310726 Antifungal, antiparasite, echinicandin B derivative |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | CA1329392C Imidazole and triazole derivatives and antiviral and radiosensitizing agents comprising same |
| 05/10/1994 | CA1329351C Microbiocidal combinations of materials and their use |
| 05/04/1994 | EP0595576A2 Stabilized sorbic acid or salt thereof |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595188A2 Process for producing vaccine for a bacterial toxin belonging to the RTX toxin family |
| 05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
| 05/04/1994 | EP0594950A1 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component |
| 05/04/1994 | EP0594795A1 Michellamines useful as antiviral agents, composition and method of treatment |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594702A1 Substituted indoles as anti-aids pharmaceuticals. |
| 05/04/1994 | EP0594677A1 Antiviral liponucleosides: treatment of hepatitis b |
| 05/04/1994 | EP0594667A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 05/04/1994 | EP0594656A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 05/04/1994 | EP0594638A1 Peptides for use in induction of t cell activation against hiv-1 |
| 05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594586A1 Hiv protease inhibitors |
| 05/04/1994 | EP0594565A1 Use of c-27 to c-32 aliphatic alcohols in antiviral treatment |
| 05/04/1994 | EP0542841B1 New synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/04/1994 | EP0487636B1 Process for preparation of an oil in water emulsion of a drug |
| 05/04/1994 | EP0387314B1 Use of an agent active against retrovirus and products so produced |
| 05/04/1994 | CN1086213A Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives |
| 05/04/1994 | CN1086143A Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/04/1994 | CN1024417C Process for manufacturing of -3-cephem-4-carboxylic acid, 1,2-propylene glycolate |
| 05/03/1994 | US5308624 Ophthalmic product |
| 05/03/1994 | CA1329198C .beta.-lactam antibiotics, processes for their preparation and their useas and in medicaments |
| 05/03/1994 | CA1329133C Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections |
| 05/03/1994 | CA1329122C Prevention of bovine respiratory disease complex in cattle by administration of interferon |
| 05/03/1994 | CA1329120C Pre-activated therapeutic agents derived from photoactive compounds |
| 04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009114A1 New bacterium causing poultry disease and vaccine derived thereof |
| 04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994008933A1 Antibiotic agents |
| 04/28/1994 | WO1994008608A1 Amino acid conjugates of cyclohexapeptidyl amines |
| 04/28/1994 | WO1994008594A1 Pharmaceutical composition containing an antimicrobial agent and an antibiotic |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | WO1994008563A1 Novel class of phosphocholine derivatives having antifungal activity |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
| 04/28/1994 | CA2146855A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | CA2146639A1 Novel class of phosphocholine derivatives having antifungal activity |